Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

4SC (Group)

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that target key indications in cancer with high unmet medical needs. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises one drug candidate in clinical development: Kinselby – resminostat. 4SC aims to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies and/or the eventual marketing and sales of approved drugs in select territories by 4SC itself. 4SC is headquartered in Planegg-Martinsried near Munich, Germany. The Company had 16 employees as of 30 June 2023 and is listed on the Prime Standard of the Frankfurt Stock Exchange (FSE Prime Standard: VSC; ISIN: DE000A3E5C40). *


Period Start 1997-01-01 established
Products Industry BIOTECH
  Industry 2 resminostat (4SC-201, Kinselby)
Persons Person Loveridge, Jason (4SC 201609– CEO)
  Person 2 Doppler, Clemens (3i Germany 2007 Director Healthcare Team)
Region Region Martinsried
  Country Germany
  Street 22 Fraunhoferstr.
  City 82152 Martinsried
  Tel +49-89-700763-0
    Address record changed: 2020-12-11
Basic data Employees B: 11 to 50 (2019-12-31)
  Currency EUR
  Annual sales 2,196,000 (revenue, consolidated (2019) 2019-12-31)
  Profit -13,962,000 (2019-12-31)
  Cash 31,727,000 (2019-12-31)
    * Document for »About Section«: 4SC AG. (9/27/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL from the US FDA". Planegg-Martinsried.
Record changed: 2023-10-01


Picture Berlin Partner Special Topic HealthCapital Berlin-Brandenburg 650x200px

More documents for 4SC (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top